Ma
Maze Ther
San Francisco CAFounded 201950 employees
Private CapbiotechPrivateRare DiseaseNeurology
Platform: Rare Lysosomal
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Doxalucimab | MAZ-7746 | Phase 1/2 | 1 | BET | OCD | ||
| Bemarelsin | MAZ-9243 | Phase 2/3 | 2 | CGRP | HNSCCLGS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)